These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7851505)

  • 1. Effects of moxonidine, an imidazoline antihypertensive agent, on second messenger systems in rat brain.
    Regunathan S; Reis DJ
    Eur J Pharmacol; 1994 Oct; 269(2):273-6. PubMed ID: 7851505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
    Urban R; Szabo B; Starke K
    Eur J Pharmacol; 1995 Aug; 282(1-3):19-28. PubMed ID: 7498275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors.
    Schäfer U; Burgdorf C; Engelhardt A; Kurz T; Richardt G
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1163-70. PubMed ID: 12438540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of sympathoinhibition by imidazolines.
    Szabo B; Urban R
    Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVL.
    Hayar A; Guyenet PG
    J Neurophysiol; 2000 Feb; 83(2):766-76. PubMed ID: 10669492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of forebrain imidazoline and alpha(2)-adrenergic receptors in the antidipsogenic response to moxonidine.
    Andrade CA; Oliveira LB; Martinez G; Silva DC; De Luca LA; Menani JV
    Ann N Y Acad Sci; 2003 Dec; 1009():262-4. PubMed ID: 15028596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport.
    Liu L; Coupar IM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1367-74. PubMed ID: 9400012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
    El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
    Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
    Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
    Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine.
    Armah BI
    Arzneimittelforschung; 1988 Oct; 38(10):1435-42. PubMed ID: 2848533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
    Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rilmenidine on signal transduction mechanisms associated with alpha 2-adrenergic and imidazoline receptors in brain.
    Regunathan S; Bramwell S; Reis DJ
    Ann N Y Acad Sci; 1995 Jul; 763():290-4. PubMed ID: 7677339
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats.
    Glavin GB; Smyth DD
    Br J Pharmacol; 1995 Feb; 114(4):751-4. PubMed ID: 7773534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference.
    Burke J; Kharlamb A; Shan T; Runde E; Padillo E; Manlapaz C; Wheeler L
    Ann N Y Acad Sci; 1995 Jul; 763():78-95. PubMed ID: 7677389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.